Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.3949
Peer-review started: December 27, 2022
First decision: March 20, 2023
Revised: April 10, 2023
Accepted: May 15, 2023
Article in press: May 15, 2023
Published online: June 16, 2023
Processing time: 166 Days and 18.4 Hours
Obscure gastrointestinal bleeding (OGIB) has traditionally been defined as gastrointestinal bleeding whose source remains unidentified after bidirectional endoscopy. OGIB can present as overt bleeding or occult bleeding, and small bowel lesions are the most common causes. The small bowel can be evaluated using capsule endoscopy, device-assisted enteroscopy, computed tomography enterography, or magnetic resonance enterography. Once the cause of small-bowel bleeding is identified and targeted therapeutic intervention is completed, the patient can be managed with routine visits. However, diagnostic tests may produce negative results, and some patients with small bowel bleeding, regar
Core Tip: Some patients with small bowel bleeding, regardless of the diagnostic findings, may experience rebleeding. Predicting those at risk of rebleeding can help clinicians form individualized surveillance plans. This article describes prediction models developed so far for identifying patients with obscure gastrointestinal bleeding who are at greater risk of rebleeding. There are prediction models that can help identify patients with a greater risk of rebleeding.
